/ Alkem's Daman Facility Gets US FDA Clearance Stocks Slightly Up ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Friday, 23 December 2016

The US FDA has issued an Establishment Inspection Report (EIR) for Alkem's Daman Facility which was inspected in September 2016. The inspection has now been closed by the US FDA. In response to the Form 483 issued by the US FDA, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. TheUS FDA has reviewed the CAPA and has found them acceptable.

Alkem Laboratories Ltd is currently trading at Rs 1626, up by Rs 17.45 or 1.08% from its previous closing of Rs 1608.55 on the BSE. The scrip opened at Rs 1615 and has touched a high and low of Rs 1640 and Rs 1604 respectively. So far 72245(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 19232.63 crore.

The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 1852.95 on 29-Sep-2016 and a 52 week low of Rs 1175 on 02-May-2016. Last one week high and low of the scrip stood at Rs 1648 and Rs 1594.2 respectively.

The promoters holding in the company stood at 66.88 % while Institutions and Non-Institutions held 7.04 % and 26.07 % respectively. The stock is currently trading below its 50 DMA.
or Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717